Soft Tissue Fixation Takes A Hit In Q421
After two quarters of significant growth, Soft Tissue Fixation took a hit in Q421, with another spike in COVID cases negatively affecting procedure volumes. 2021 was a year full of ups and downs due mainly to the COVID pandemic and Q4 was no different. COVID once again brought a new wave of cases, with the Omicron variant taking its toll on Soft Tissue Fixation case volumes resulting in modest YoY revenue declines over 2020.
Among the many topics covered in detail in our comprehensive Q421 Soft Tissue Fixation Market Recap* are:
- Complete Q421/FY21 Soft Tissue Fixation Market Overview
- SmartTRAK's Expert Analysis and Insights
- All Market News including Revenues, Data, Charts and Shares
- Top Competitor Results & Highlights
- Q421 Clinical/Regulatory Events and Highlights
In terms of case volumes, the US seemed to be hit hardest from Omicron whereas Europe and other parts of the world saw some restrictions being lifted. That along with some pent-up demand, especially in the socialized medicine countries, led to some elective procedures increasing in these markets. The COVID surge in Q421 seemed to hit the hardest in the latter part of the quarter with reports of ...
*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
SmartTRAK now offers Skin Substitutes (CTP) Site of Care. This module will make you an expert in Site of Care information for the Skin Substitutes market. Receive market shares, 5-Year Growth Projections and Company & Product Performance across multiple sites of care. Download our PDF to get a preview of what's available!
